Imperial Collider: Health - Innovations for partners, people & populations

Imperial Collider returns, providing you the opportunity to meet world-leading researchers across Imperial's health and innovation ecosystem. Come along to hear from startup and spinout founders from our community, representatives from funding and investment organisations, and leading industry figures in health, pharma and biosciences.

This year, our keynote speaker is Dr Fiona Marshall, President of Biomedical Research at Novartis, who will bring her extensive experience and cross-cutting expertise to inspire impact-making innovation throughout the community.

***SCROLL TO THE BOTTOM OF THE PAGE TO VIEW THE FULL AGENDA***

• Direct access to top voices in biomedical innovation from Imperial, pharma, investment, and translational research.
• High-value networking opportunities with academics, founders, funders, and R&D leaders.
• Practical insight into the biomedical sector landscape, including key trends, partnerships, funding, and innovation pathways.
• Real examples of translational success, including topics like GLP biology, rhinovirus vaccines, antimicrobial resistance, precision medicine, and digital health.
• Strong emphasis on partnership-building, helping attendees identify collaborators and routes to commercial or clinical impact.
• Relevant for both early-career and senior attendees, whether they are seeking funding, industry links, research partners, or strategic insight.

PartneringONE is a powerful online platform that will enable speed meeting, in advance.

• Targeted matchmaking through a full day of curated 1:1 speed meetings.
• Efficient, high-value conversations with each meeting lasting 25 minutes, ideal for focused introductions and opportunity scouting.
• Dedicated online partnering platform for a smooth and structured meeting experience.
• Advance profile browsing so participants can identify the most relevant organisations and individuals before the event.
• Pre-scheduled tailored agendas that maximise time, relevance, and meeting outcomes.
• Streamlined networking experience combining smart planning tools with productive live interactions.

• Imperial academics and researchers working in pharmaceuticals, drug discovery, healthcare and medtech
• Early career researchers at Imperial looking for industry partners or support applying for grants and funding
• Research and development leaders at medical companies are looking for an academic partner or inspiration on breakthrough areas of science

• Please complete your registration in full to confirm your job title, company, and dietary and accessibility requirements.
• This is a ticketed event with limited space. We reserve the right to cancel your ticket.
• There will be photography and filming at this event.
• For venue accessibility information, please contact Prashanthini (Prasshy) Jeyarajan: [email protected]
• Please return all digital/print lanyards, or a fine may be incurred.
• All guests registering for this event will be expected to adhere to Imperial’s Institutional Events code of conduct.
• Imperial College London – Enterprise Division Privacy Notice

For all other questions, please contact Prashanthini (Prasshy) Jeyarajan: [email protected]

Info: An introduction to Imperial Collider 2026, setting the vision for how academia, healthcare, biotech and pharma can work together to accelerate translational research, innovation and real-world impact.

Info: An industry perspective on the technologies reshaping biomedical research, drug discovery and healthcare delivery, and what this means for the future of translational science and partnerships.

Info: Exploring the translational journey from foundational metabolic research at Imperial College London through to the development of differentiated next-generation metabolic therapeutics. The session will reflect on the scientific, strategic and partnership considerations involved in advancing therapies towards clinical development.

Info: Exploring the development of a cross-reactive rhinovirus vaccine and the scientific, translational and clinical challenges involved in bringing novel respiratory vaccines towards human studies.

Info: How academia and industry are working together through the Fleming Initiative to address antimicrobial resistance and accelerate the development of next-generation infectious disease solutions.

Info: A discussion on how the biomedical innovation model is evolving across academia, biotech and pharma. The panel will explore AI-enabled discovery, precision medicine, translational ecosystems, emerging scientific frontiers, and the changing role of universities in shaping the future of healthcare innovation.

Info: How enabling technologies, diagnostics, analytics and data-driven approaches are transforming pharmaceutical R&D, manufacturing and precision medicine.

Info: An overview of Imperial’s unique clinical ecosystem, demonstrating how patient access, NHS integration and translational infrastructure support large-scale biomedical innovation.

Info: Exploring how AI, digital health and data science are converging with biomedical research to create new opportunities for healthcare innovation and translational impact.

Info: Industry partnership leaders discuss what makes collaborations successful, how promising science is identified, and how academia and industry can build high-impact translational partnerships

Info: A rapid showcase of emerging Imperial translational science programmes spanning engineering biology, cell therapy, digital health and advanced therapeutics with strong commercial and clinical potential.

Info: Closing reflections on the day’s discussions, the importance of sustained collaboration, and the next steps for strengthening Imperial’s translational and partnership ecosystem.

Know what’s Happening Next — before everyone else does.

Get App

Host or Publisher Imperial Enterprise